StockData

VitaSpring Biomedical Co. Ltd. (VSBC) stock

VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 17, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $6.58MP/E –Yield –

VitaSpring Biomedical cash

Cash and short-term investments held at the end of each period.

VitaSpring Biomedical's cash was $13.37K at Jul 31, 2026. For fiscal 2026 it was $2.08K, up 666.2% from the year before. The highest annual figure on record is $107.21K in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2026Jan 31, 2026$2.08K+666.2%
FY2025Jan 31, 2025$272+1992.3%
FY2024Jan 31, 2024$13-100.0%
FY2023Jan 31, 2023$29.66K-72.3%
FY2022Jan 31, 2022$107.21K+136.2%
FY2021Jan 31, 2021$45.40K–
FY2020Jan 31, 2020$0-100.0%
FY2019Jan 31, 2019$105-98.0%
FY2018Jan 31, 2018$5.21K+838.2%
FY2017Jan 31, 2017$555–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2027CQ2 2026Jul 31, 2026$13.37K+1573.0%
Q1 FY2027CQ1 2026Apr 30, 2026$8.17K–
Q4 FY2026CQ4 2025Jan 31, 2026$2.08K+666.2%
Q3 FY2026CQ3 2025Oct 31, 2025$0-100.0%
Q2 FY2026CQ2 2025Jul 31, 2025$799-85.5%
Q1 FY2026CQ1 2025Apr 30, 2025$0-100.0%
Q4 FY2025CQ4 2024Jan 31, 2025$272+1992.3%
Q3 FY2025CQ3 2024Oct 31, 2024$2.06K-21.8%
Q2 FY2025CQ2 2024Jul 31, 2024$5.53K-23.1%
Q1 FY2025CQ1 2024Apr 30, 2024$968-67.7%
Q4 FY2024CQ4 2023Jan 31, 2024$13-100.0%
Q3 FY2024CQ3 2023Oct 31, 2023$2.64K-89.0%
Q2 FY2024CQ2 2023Jul 31, 2023$7.18K-66.7%
Q1 FY2024CQ1 2023Apr 30, 2023$2.99K-96.2%
Q4 FY2023CQ4 2022Jan 31, 2023$29.66K-72.3%
Q3 FY2023CQ3 2022Oct 31, 2022$24.05K-88.8%
Q2 FY2023CQ2 2022Jul 31, 2022$21.59K-96.5%
Q1 FY2023CQ1 2022Apr 30, 2022$79.15K-80.4%
Q4 FY2022CQ4 2021Jan 31, 2022$107.21K+136.2%
Q3 FY2022CQ3 2021Oct 31, 2021$214.06K+29303.4%
Q2 FY2022CQ2 2021Jul 31, 2021$614.06K+84249.3%
Q1 FY2022CQ1 2021Apr 30, 2021$404.26K+45169.5%
Q4 FY2021CQ4 2020Jan 31, 2021$45.40K–
Q3 FY2021CQ3 2020Oct 31, 2020$728+443.3%
Q2 FY2021CQ2 2020Jul 31, 2020$728+74.2%
Q1 FY2021CQ1 2020Apr 30, 2020$893-44.9%
Q4 FY2020CQ4 2019Jan 31, 2020$0-100.0%
Q3 FY2020CQ3 2019Oct 31, 2019$134-71.4%
Q2 FY2020CQ2 2019Jul 31, 2019$418-22.2%
Q1 FY2020CQ1 2019Apr 30, 2019$1.62K-50.6%
Q4 FY2019CQ4 2018Jan 31, 2019$105-98.0%
Q3 FY2019CQ3 2018Oct 31, 2018$468+20.9%
Q2 FY2019CQ2 2018Jul 31, 2018$537-42.9%
Q1 FY2019CQ1 2018Apr 30, 2018$3.28K+29.1%
Q4 FY2018CQ4 2017Jan 31, 2018$5.21K+838.2%
Q3 FY2018CQ3 2017Oct 31, 2017$387–
Q2 FY2018CQ2 2017Jul 31, 2017$941–
Q1 FY2018CQ1 2017Apr 30, 2017$2.54K–
Q4 FY2017CQ4 2016Jan 31, 2017$555–

More VitaSpring Biomedical figures

See a number that looks wrong?